Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions
RE Harskamp, RD Lopes, CE Baisden… - Annals of …, 2013 - journals.lww.com
Objective: To review our current understanding of the epidemiology and pathogenesis of
vein graft failure (VGF), give an overview of current preventive and interventional measures …
vein graft failure (VGF), give an overview of current preventive and interventional measures …
Impact of cardiac rehabilitation and exercise training programs in coronary heart disease
S Kachur, V Chongthammakun, CJ Lavie… - Progress in …, 2017 - Elsevier
Cardiovascular rehabilitation (CR) is the process of developing and maintaining an optimal
level of physical, social, and psychological well-being in order to promote recovery from …
level of physical, social, and psychological well-being in order to promote recovery from …
Microfluidic bioprinting of tough hydrogel-based vascular conduits for functional blood vessels
Three-dimensional (3D) bioprinting of vascular tissues that are mechanically and
functionally comparable to their native counterparts is an unmet challenge. Here, we …
functionally comparable to their native counterparts is an unmet challenge. Here, we …
Surgical site infection in cardiac surgery
A Zukowska, M Zukowski - Journal of Clinical Medicine, 2022 - mdpi.com
Surgical site infections (SSIs) are one of the most significant complications in surgical
patients and are strongly associated with poorer prognosis. Due to their aggressive …
patients and are strongly associated with poorer prognosis. Due to their aggressive …
Understanding the volume-outcome effect in cardiovascular surgery: the role of failure to rescue
AA Gonzalez, JB Dimick, JD Birkmeyer… - JAMA …, 2014 - jamanetwork.com
Importance To effectively guide interventions aimed at reducing mortality in low-volume
hospitals, the underlying mechanisms of the volume-outcome relationship must be further …
hospitals, the underlying mechanisms of the volume-outcome relationship must be further …
[HTML][HTML] Stopping vs. continuing aspirin before coronary artery surgery
Background Most patients with coronary artery disease receive aspirin for primary or
secondary prevention of myocardial infarction, stroke, and death. Aspirin poses a risk of …
secondary prevention of myocardial infarction, stroke, and death. Aspirin poses a risk of …
2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and …
2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary
artery bypass grafting in patients with ischemic cardiomyopathy and heart failure - The Journal …
artery bypass grafting in patients with ischemic cardiomyopathy and heart failure - The Journal …
Dual antiplatelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and metaanalysis
Background Antiplatelet therapy is an important component of medical therapy post
coronary artery bypass grafting (CABG). While aspirin administration is a Class I indication …
coronary artery bypass grafting (CABG). While aspirin administration is a Class I indication …
Management and prevention of saphenous vein graft failure: a review
P McKavanagh, B Yanagawa, G Zawadowski… - Cardiology and …, 2017 - Springer
Coronary artery bypass grafting (CABG) remains a vital treatment for patients with
multivessel coronary artery disease (CAD), especially diabetics. The long-term benefit of the …
multivessel coronary artery disease (CAD), especially diabetics. The long-term benefit of the …
The SYNTAX score and its clinical implications
SJ Head, V Farooq, PW Serruys, AP Kappetein - Heart, 2014 - heart.bmj.com
Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are
both treatment options for coronary revascularisation in selected patients with stable …
both treatment options for coronary revascularisation in selected patients with stable …